An AI model (REDMOD) can pick up the very early subtle tissue changes of pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer, which conventional imaging and the human eye find difficult to detect, finds research published online in the journal Gut. As such, it offers the potential to shift an all too common late stage, terminal disease diagnosis to one that is at an early stage (stage 0) and treatable, say the researchers. While REDMOD was more accurate than experienced radiologists, it requires testing in high risk patients, defined as those with unexpected weight loss and newly diagnosed diabetes, before it can be widely used in clinical practice, they add.
AI Spots Pancreatic Cancer Years Before It Shows Up, Study Finds
An artificial intelligence system can spot pancreatic cancer long before it shows up on scans, raising the prospect of catching one of the deadliest tumors early enough to successfully treat, a study found.
Next-generation AI for visually occult pancreatic cancer detection in a low-prevalence setting with longitudinal stability and multi-institutional generalisability
Background Failure of conventional imaging to detect pancreatic ductal adenocarcinoma (PDA) at its visually occult pre-diagnostic stage is a primary barrier to improving its otherwise poor rate of survival. Objective To develop and validate the Radiomics-based Early Detection MODel (REDMOD), an AI framework to identify subvisual radiomic signatures of pre-diagnostic PDA on standard-of-care CT. Designs REDMOD was trained on a multi-institutional cohort (n=969; 156 pre-diagnostic, 813 control) and tested on an independent set (n=493; 63 pre-diagnostic, 430 control), simulating a low prevalence (~1:6) early detection paradigm. The fully automated framework couples AI-driven segmentation with a heterogeneous ensemble architecture trained on a 40-feature radiomic signature derived from Synthetic Minority Over-sampling Technique (SMOTE)-balanced data. A tunable Youden Index-optimised classification threshold enables performance calibration without retraining. Validation included direct comparison with radiologists, longitudinal test–retest analysis and external specificity validation across two independent cohorts (n=539 and n=80). Results On an independent test set (n=493), REDMOD identified occult PDA (AUC 0.82; 73.0% sensitivity) at a median 475-day lead time. This represented nearly twofold higher sensitivity than radiologists (38.9%; p<0.001), which grew to nearly threefold (68.0% vs 23.0%) at >24 months lead time. REDMOD showed strong longitudinal stability (90–92% concordance) and generalisable specificity across multi-institutional (81.3%; n=539) and public (87.5%; n=80) datasets. Mechanistic analyses confirmed predictive power derived principally from multi-scale wavelet-filtered textural features (90% of selected signature), which outperformed unfiltered features (AUC 0.82 vs 0.74; p=0.007) in capturing subvisual architectural disruptions. Conclusions REDMOD is an automated, mechanistically grounded, longitudinally stable, externally validated AI that surpasses radiologists for PDA detection at its visually occult pre-diagnostic stage. These attributes position it for prospective validation in high-risk cohorts, a necessary step towards shifting the paradigm from late-stage symptomatic diagnosis to proactive pre-clinical interception.
Using AI Made Doctors Worse at Spotting Cancer Without Assistance
A new study offers the latest evidence of potential “deskilling” effects on AI users.
Pancreatic cancer mRNA vaccine shows lasting results in an early trial
Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later.
Fred Hutch researchers test privacy-first AI platform for cancer research
Researchers at Fred Hutch Cancer Center are testing whether a collaborative AI research platform can accelerate the pace of cancer research leading to faster diagnoses and more precise, targeted therapies, especially for rare types of cancers while safeguarding patient privacy.
The algorithm will see you now - Works in Progress Magazine
Radiology combines digital images, clear benchmarks, and repeatable tasks. But replacing humans with AI is harder than it seems.
AI can detect heart disease in women using mammograms, study suggests
Experts say findings mean breast screenings for cancer could also flag cardiovascular problems in women
Foundation Models in Medical Imaging: A Review and Outlook
Foundation models (FMs) are changing the way medical images are analyzed by learning from large collections of unlabeled data. Instead of relying on manually annotated examples, FMs are...
AI linked to explosion of low-quality biomedical research papers
Analysis flags hundreds of studies that seem to follow a template, reporting correlations between complex health conditions and single variables based on publicly available data sets.
Things that Apparently Cause Cancer
What does this methodology measure anyway?
It’s remarkably easy to inject new medical misinformation into LLMs
Changing just 0.001% of inputs to misinformation makes the AI less accurate.
Meta’s New AI Asked for My Raw Health Data—and Gave Me Terrible Advice
Meta’s Muse Spark model offers to analyze users’ health data, including lab results. Beyond the obvious privacy risks, it’s not a capable stand-in for a real doctor.
International, cross-sector collaboration commits nearly $2 billion to build foundational data for AI models to predict and treat disease
Biohub, DOE, NIH, and partners will generate open, standardized data to train AI models that predict how cells respond to interventions.
Amy Deng on Twitter / X
I’m an AI researcher turned brain tumor patient, and recently I used the models to crack my mystery fatigue faster than my PCP could. I believe everyone can do the same with their own symptoms. Here’s how: pic.twitter.com/0jhbPvEi7V— Amy Deng (@amydeng_) June 16, 2026
#Pancreaticcancer is usually caught too late to treat. A new study finds an #AI system can pick up early warning signs in routine CT scans more than a year before diagnosis -- outperforming radiologists on scans previously read as normal. Hopefully it can improve survival. shorturl.at/zXUwj
AI Spots Pancreatic Cancer Years Before It Shows Up, Study Finds
www.bloomberg.com